The burden of treatment in people living with type 2 diabetes: A qualitative study of patients and their primary care clinicians.
The burden of treatment in people living with type 2 diabetes: A qualitative study of patients and their primary care clinicians.
复制标题
DOI:
10.1371/journal.pone.0241485
复制
发表时间:
2020
期刊:
影响因子:
3.7
通讯作者:
Montori VM
中科院分区:
文献类型:
--
作者:
Espinoza P;Varela CA;Vargas IE;Ortega G;Silva PA;Boehmer KB;Montori VM
The burden of treatment can overwhelm people living with type 2 diabetes and lead to poor treatment fidelity and outcomes. Chronic care programs must consider and mitigate the burden of treatment while supporting patients in achieving their goals. To explore what patients with type 2 diabetes and their health providers consider are the workload and the resources they must mobilize, i.e., their capacity, to shoulder it. We conducted focus groups comprised of 30 patients and 32 clinicians from three community health centers in Chile implementing the Chronic Care Model to reduce cardiovascular risk in patients with type 2 diabetes. Transcripts were analyzed using thematic content analysis techniques illuminated by the Minimally Disruptive Medicine framework. Gaining access to and working with their clinicians, implementing complex medication regimens, and changing lifestyles burdened patients. To deal with the distress of the diagnosis, difficulties achieving disease control, and fear of complications, patients drew capacity from their family (mostly men), social environment (mostly women), lay expertise, and spirituality. Clinicians found that administrative tasks, limited formulary, and protocol rigidity hindered their ability to modify care plans to reduce patient workload and support their capacity. Chronic primary care programs burden patients living with type 2 diabetes while hindering clinicians’ ability to reduce treatment workloads or support patient capacity. A collaborative approach toward Minimally Disruptive Medicine may result in treatments that fit the lives and loves of patients and improve outcomes.
登录
查看更多内容
影响因子:
2.2
作者:
Polonsky WH;Henry RR
通讯作者:
Henry RR
影响因子:
5.7
作者:
Spencer-Bonilla, Gabriela;Quinones, Ana R.;Montori, Victor M.
通讯作者:
Montori, Victor M.
影响因子:
39.2
作者:
Heisler M;Choi H;Palmisano G;Mase R;Richardson C;Fagerlin A;Montori VM;Spencer M;An LC
通讯作者:
An LC
DOI:
10.2337/cd18-0105
发表时间:
2019-01-01
期刊:
Clinical diabetes : a publication of the American Diabetes Association
影响因子:
--
作者:
通讯作者:
--
DOI:
10.4067/s0034-98872017000500012
发表时间:
2017-05-01
期刊:
Revista médica de Chile
影响因子:
--
作者:
Serrano, Valentina;Larrea-Mantilla, Laura;Montori, Víctor M
通讯作者:
Montori, Víctor M